Introduction
The Turkish Association for Psychopharmacology (TAP) was
established in 2005, is the nation’s premier
professional society in brain and psychopharmacology
research. TAP’s core purpose is to advance scientific
understanding of mental illnesses and to facilitate the
communication and collaboration between convergent
disciplines such as pre-clinical, clinical, and
pharmaceutical industry in the field of
psychopharmacology. To achieve this goal, The TAP
arranges scientific meetings, fosters research and
teaching, encourages publication of primary data
research and provides guidance and information to the
public on matters relevant to psychopharmacology.
The TAP organizes scientific meetings and symposia
during the course of the year from basic research to
pharmaceutical development and clinical application. In
recent years, the TAP has begun to produce a range of
consensual statements on the treatment of clinical
disorders as well as the investigation of
psychopharmaceutical compounds.
Among the other objectives of the TAP are; professional
improvement of psychiatrists, neurologists, basic
scientists (physiologists, pharmacologists, geneticists,
etc.) who share a common interest in psychopharmacology,
to establish the standards of psychopharmacology
education (of medical school students, psychiatry
residents, and other residents) and to operate at the
highest level in the conduct of this training, and also
to represent the psychopharmacology field in the
commissions held by the Ministry of Health and Turkish
Medical Association and to share expert opinion in such
meetings.
The TAP encourages the primary data research in the
field of psychiatry and psychopharmacology, funds
researchers, ensures the quality of the research and
disseminates relevant advances in the field with its
publications. The TAP is committed to provide the best
information available to mental health professionals, as
well as to patients and patient representative groups
The TAP is committed to open dialogues with other
scientific associations, foundations, unions, and also
non-governmental organizations to establish a common
platform in psychophramacology and related fields.
Bulletin of Clinical Psychopharmacology, as a quarterly published English-Turkish, referee based journal since1990, timely publication is a principle. Bulletin of Clinical Psychopharmacology is a journal cited by highly reputable databases (especially SCI-E). Bulletin of Clinical Psychopharmacology especially publishes experimental, basic or clinical papers about research in the fields of psychopharmacology, behavioral sciences as well as pediatric.
Journal of Mood Disorders is a publication of Turkish Associaton for Psychopharmacology Mood Disorders Section (TAP-MooDS). Journal is focused on bipolar, unipolar mood disorders and anxiety disorders.
